Growth Hormone in a Patient With a Dominant-Negative GHR Mutation
Clinical trial NCT05382637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05382637
- Sponsor
- Children's National Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-26
- Primary completion
- 2023-09-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.